Table 3.
Total Stroke | Ischemic Stroke | |||||||
---|---|---|---|---|---|---|---|---|
Q4 vs Q1 | P Value | Per 1‐SDa | P Value | Q4 vs Q1 | P Value | Per 1‐SDa | P Value | |
Plasma Met | ||||||||
Unadjusted | 0.92 (0.54–1.57) | 0.77 | 0.88 (0.74–1.06) | 0.19 | 0.93 (0.51–1.67) | 0.81 | 0.89 (0.73–1.09) | 0.89 |
Model 1b | 1.04 (0.61–1.78) | 0.88 | 0.92 (0.76–1.09) | 0.35 | 1.05 (0.58–1.89) | 0.88 | 0.93 (0.76–1.13) | 0.44 |
Model 2c | 1.02 (0.60–1.75) | 0.93 | 0.91 (0.76–1.08) | 0.29 | 1.01 (0.55–1.83) | 0.98 | 0.91 (0.75–1.11) | 0.37 |
Model 3d | 0.91 (0.51–1.62) | 0.75 | 0.87 (0.73–1.06) | 0.18 | 0.90 (0.48–1.75) | 0.79 | 0.88 (0.71–1.08) | 0.23 |
Plasma tHcy | ||||||||
Unadjusted | 2.63 (1.55–4.44) | <0.001 | 1.40 (1.21–1.61) | <0.001 | 2.74 (1.55–4.83) | <0.001 | 1.44 (1.23–1.69) | <0.001 |
Model 1b | 1.76 (1.01–3.04) | 0.05 | 1.27 (1.08–1.50) | 0.003 | 1.87 (1.03–3.38) | 0.04 | 1.32 (1.11–1.59) | 0.002 |
Model 2c | 1.49 (0.85–2.60) | 0.16 | 1.21 (1.02–1.45) | 0.04 | 1.57 (0.86–2.87) | 0.14 | 1.24 (1.03–1.54) | 0.03 |
Model 3d | 1.27 (0.72–2.28) | 0.39 | 1.14 (0.95–1.39) | 0.12 | 1.30 (0.71–2.43) | 0.40 | 1.16 (0.97–1.44) | 0.10 |
Plasma tCys | ||||||||
Unadjusted | 3.38 (1.91–5.97) | <0.001 | 1.49 (1.26–1.76) | <0.001 | 2.88 (1.51–5.47) | <0.001 | 1.37 (1.14–1.65) | 0.001 |
Model 1b | 1.80 (0.99–3.29) | 0.54 | 1.16 (0.96–1.41) | 0.10 | 1.51 (0.77–2.97) | 0.23 | 1.06 (0.87–1.31) | 0.56 |
Model 2c | 1.75 (0.95–3.21) | 0.07 | 1.13 (0.93–1.36) | 0.20 | 1.44 (0.7–2.85) | 0.29 | 1.02 (0.83–1.26) | 0.84 |
Model 3d | 1.63 (0.89–3.01) | 0.12 | 1.10 (0.91–1.33) | 0.31 | 1.31 (0.66–2.61) | 0.44 | 0.98 (0.81–1.22) | 0.96 |
Met indicates methionine; Q1, first quartile; Q4, fourth quartile; tCyst, total cysteine; tHcy, total homocysteine.
Log‐transformed.
Adjusted for age and sex.
Adjusted for variables in model 1 plus obesity, diabetes mellitus, hypertension, smoking, previous myocardial infarction, and atrial fibrillation.
Adjusted for variables in model 2 plus plasma cystathionine.